PT  - JOURNAL ARTICLE
AU  - Hoyle, Brian
ED  - Kieseier, Bernd C.
TI  - ADVANCE Results: PEG-IFN-β-1a Decreases Disability in RRMS
DP  - 2014 Jul 01
TA  - MD Conference Express
PG  - 7--7
VI  - 14
IP  - 29
4099  - http://mdc.sagepub.com/content/14/29/7.short
4100  - http://mdc.sagepub.com/content/14/29/7.full
AB  - Two-year data from the Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis [ADVANCE; NCT00906399; Kieseier BC et al. ECTRIMS 2014 (poster P042)], a study of relapsing-remitting multiple sclerosis (RRMS) in more than 1500 patients, have confirmed the long-term capability of subcutaneously injected peginterferon beta-1a (PEG-IFN-β-1a) in lessening disability progression.